SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001193125-21-102233
Filing Date
2021-03-31
Accepted
2021-03-31 16:01:30
Documents
64
Period of Report
2021-02-28

Document Format Files

Seq Description Document Type Size
1 10-Q d10299d10q.htm   iXBRL 10-Q 1232505
2 EX-31.1 d10299dex311.htm EX-31.1 10710
3 EX-31.2 d10299dex312.htm EX-31.2 10790
4 EX-32 d10299dex32.htm EX-32 5326
  Complete submission text file 0001193125-21-102233.txt   5840245

Data Files

Seq Description Document Type Size
5 XBRL TAXONOMY EXTENSION SCHEMA neog-20210228.xsd EX-101.SCH 35625
6 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE neog-20210228_cal.xml EX-101.CAL 37802
7 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE neog-20210228_def.xml EX-101.DEF 269101
8 XBRL TAXONOMY EXTENSION LABEL LINKBASE neog-20210228_lab.xml EX-101.LAB 337515
9 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE neog-20210228_pre.xml EX-101.PRE 306744
10 EXTRACTED XBRL INSTANCE DOCUMENT d10299d10q_htm.xml XML 1118693
Mailing Address 620 LESHER PLACE LANSING MI 48912
Business Address 620 LESHER PLACE LANSING MI 48912 5173729200
NEOGEN CORP (Filer) CIK: 0000711377 (see all company filings)

IRS No.: 382367843 | State of Incorp.: MI | Fiscal Year End: 0531
Type: 10-Q | Act: 34 | File No.: 000-17988 | Film No.: 21793160
SIC: 2835 In Vitro & In Vivo Diagnostic Substances